KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $6.6 billion.

  • Resmed's Retained Earnings rose 2103.49% to $6.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.6 billion, marking a year-over-year increase of 2103.49%. This contributed to the annual value of $6.1 billion for FY2025, which is 2183.33% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Retained Earnings is $6.6 billion, which was up 2103.49% from $6.3 billion recorded in Q3 2025.
  • Resmed's Retained Earnings' 5-year high stood at $6.6 billion during Q4 2025, with a 5-year trough of $2.9 billion in Q1 2021.
  • Its 5-year average for Retained Earnings is $4.5 billion, with a median of $4.3 billion in 2023.
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 847.08% in 2021, then surged by 2183.33% in 2025.
  • Quarter analysis of 5 years shows Resmed's Retained Earnings stood at $3.4 billion in 2021, then rose by 16.58% to $3.9 billion in 2022, then increased by 15.81% to $4.5 billion in 2023, then grew by 20.97% to $5.5 billion in 2024, then increased by 21.03% to $6.6 billion in 2025.
  • Its last three reported values are $6.6 billion in Q4 2025, $6.3 billion for Q3 2025, and $6.1 billion during Q2 2025.